Suppr超能文献

川崎病患者的血管和内皮功能评估。

Assessment of vascular and endothelial function in Kawasaki disease.

机构信息

Department of Pediatrics, Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Department of Pediatrics, Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

出版信息

Biomed J. 2023 Apr;46(2):100525. doi: 10.1016/j.bj.2022.03.010. Epub 2022 Mar 28.

Abstract

BACKGROUND

Kawasaki disease (KD) is an acute febrile vasculitis. Patients with previous KD have increased risk of coronary arterial aneurysms (CAA) and early-onset arteriosclerosis. Endothelial dysfunction is the earliest manifestation of arteriosclerosis. We aimed to explore the endothelial function and clinical characteristics of patients with previous KD.

METHODS

In this case-control study, we investigated childhood KD patients, with and without CAA, and a group of healthy controls. We obtained the anthropometric measurements, metabolic markers, vascular ultrasonography evaluating arterial stiffness and flow-mediated dilatation (FMD), and clinical information obtained by reviewing the patients' charts. Continuous variables were compared using non-parametric analyses and categorical variables, using the chi-square or Fisher's exact tests.

RESULTS

Seventy KD patients (median current age, 12.95 years; median follow-up duration, 10.88 years) and 14 healthy controls were recruited. FMD was significantly lower in the CAA group (n = 15) than the control group (FMDs: 5.59% [interquartile range, 3.99-6.86%] vs. 7.49% [5.96-9.42%], p = 0.049; diastolic FMD: 6.48% [4.14-7.32%] vs. 7.87% [6.19-9.98%], p = 0.042). The CAA group had a higher percentage of impaired FMD and the significantly largest coronary segments of the three groups. Other parameters including metabolic markers, carotid intima-media thickness, and arterial stiffness were not statistically different.

CONCLUSION

KD patients, especially those with CAAs, may have impaired endothelial function. FMD may be a good indicator of endothelial dysfunction for use in long-term follow-up of KD patients.

摘要

背景

川崎病(KD)是一种急性发热性血管炎。既往患有 KD 的患者发生冠状动脉瘤(CAA)和早发动脉粥样硬化的风险增加。内皮功能障碍是动脉粥样硬化的最早表现。我们旨在探讨既往 KD 患者的内皮功能和临床特征。

方法

在这项病例对照研究中,我们调查了伴有和不伴有 CAA 的儿童 KD 患者和一组健康对照者。我们通过查阅患者病历获得了人体测量学指标、代谢标志物、评估动脉僵硬度和血流介导的扩张(FMD)的血管超声检查结果以及临床信息。使用非参数分析比较连续变量,使用卡方检验或 Fisher 确切概率法比较分类变量。

结果

共纳入 70 例 KD 患者(中位数当前年龄为 12.95 岁;中位数随访时间为 10.88 年)和 14 名健康对照者。与对照组相比,CAA 组(n=15)的 FMD 显著降低(FMD:5.59%[四分位距 3.99%-6.86%] vs. 7.49%[5.96%-9.42%],p=0.049;舒张期 FMD:6.48%[4.14%-7.32%] vs. 7.87%[6.19%-9.98%],p=0.042)。CAA 组 FMD 受损的比例更高,三组中冠状动脉节段最大的比例也明显更高。其他参数,包括代谢标志物、颈动脉内膜中层厚度和动脉僵硬度,无统计学差异。

结论

KD 患者,尤其是伴有 CAA 的患者,内皮功能可能受损。FMD 可能是 KD 患者长期随访中内皮功能障碍的良好指标。

相似文献

1
Assessment of vascular and endothelial function in Kawasaki disease.
Biomed J. 2023 Apr;46(2):100525. doi: 10.1016/j.bj.2022.03.010. Epub 2022 Mar 28.
3
Endothelial dysfunction in children within 5 years after onset of Kawasaki disease.
J Pediatr. 2013 Oct;163(4):1117-21. doi: 10.1016/j.jpeds.2013.04.046. Epub 2013 Jun 5.
5
Cardiovascular status after Kawasaki disease in the UK.
Heart. 2015 Oct;101(20):1646-55. doi: 10.1136/heartjnl-2015-307734. Epub 2015 Aug 27.
6
Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease.
Pediatr Cardiol. 2005 Jul-Aug;26(4):385-90. doi: 10.1007/s00246-004-0755-9.
8
Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.
World J Pediatr. 2014 Aug;10(3):232-7. doi: 10.1007/s12519-014-0498-5. Epub 2014 Aug 15.
9
Extracardial Vasculopathy After Kawasaki Disease: A Long-Term Follow-up Study.
J Am Heart Assoc. 2016 Jul 5;5(7):e003414. doi: 10.1161/JAHA.116.003414.

引用本文的文献

2
An Update on Kawasaki Disease.
Curr Rheumatol Rep. 2024 Dec 3;27(1):4. doi: 10.1007/s11926-024-01167-4.
3
Coronary Arteries Lesions in Kawasaki Disease: Risk Factors in an Italian Cohort.
Biomedicines. 2024 Sep 3;12(9):2010. doi: 10.3390/biomedicines12092010.
5
Markers of Endothelial Dysfunction in Kawasaki Disease: An Update.
Clin Rev Allergy Immunol. 2024 Feb;66(1):99-111. doi: 10.1007/s12016-024-08985-5. Epub 2024 Mar 11.
6
CircRNA7632 down-regulation alleviates endothelial cell dysfunction in Kawasaki disease via regulating IL-33 expression.
Cell Stress Chaperones. 2023 Jul;28(4):363-374. doi: 10.1007/s12192-023-01333-0. Epub 2023 May 11.
7
When it doesn't run in the blood(vessels) - events involved in vascular disorders.
Biomed J. 2023 Apr;46(2):100591. doi: 10.1016/j.bj.2023.03.004. Epub 2023 Apr 13.

本文引用的文献

1
JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease.
Circ J. 2020 Jul 22;84(8):1348-1407. doi: 10.1253/circj.CJ-19-1094. Epub 2020 Jul 8.
2
2020 International Society of Hypertension Global Hypertension Practice Guidelines.
Hypertension. 2020 Jun;75(6):1334-1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. Epub 2020 May 6.
4
Recent updates on echocardiography and ultrasound for Kawasaki disease: beyond the coronary artery.
Cardiovasc Diagn Ther. 2018 Feb;8(1):80-89. doi: 10.21037/cdt.2017.06.09.
6
Evaluation of endothelial dysfunction, endothelial plasma markers, and traditional metabolic parameters in children with adiposity.
J Formos Med Assoc. 2019 Jan;118(1 Pt 1):83-91. doi: 10.1016/j.jfma.2018.01.007. Epub 2018 Feb 1.
7
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.
Pediatrics. 2017 Sep;140(3). doi: 10.1542/peds.2017-1904. Epub 2017 Aug 21.
8
Measurement of Flow-Mediated Vasodilatation.
Int Heart J. 2017 Apr 6;58(2):158-162. doi: 10.1536/ihj.17-013. Epub 2017 Mar 27.
10
A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population.
J Am Soc Echocardiogr. 2016 Aug;29(8):794-801.e29. doi: 10.1016/j.echo.2016.03.017. Epub 2016 Jun 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验